Ribosomal protein L11 pseudogene 4 (RPL11P4)

Ribosomal protein L11 pseudogene 4 (RPL11P4) is one of several processed pseudogenes related to the ribosomal protein L11 gene. Pseudogenes are evolutionarily derived, mutated copies of protein-coding genes that generally do not encode functional proteins. However, pseudogenes can regulate their associated protein-coding genes through mechanisms such as serving as competing endogenous RNAs (ceRNAs), acting as microRNA sponges, or modifying gene expression via RNA interference. Some ribosomal protein pseudogenes have been implicated in fine-tuning ribosomal protein levels under stress or pathological conditions by modulating the transcript abundance of their parent genes, although the specific biological or disease relevance of RPL11P4 has not been independently established. RPL11P4 is neither a protein-coding gene nor a canonical therapeutic target; its biological function, druggability, and biomarker utility remain unproven or are unknown[2][8]. Key context: - True ribosomal proteins, such as Ribosomal protein L11 (RPL11), participate directly in ribosome biogenesis, translation, and cell regulation, and deletions or mutations may cause human diseases such as Diamond-Blackfan anemia[1][7]. - By contrast, RPL11P4 is a non-coding, processed pseudogene as typical for many ribosomal protein genes, existing as genomic “fossils” that rarely (if ever) encode functional proteins, but can occasionally regulate their parent genes through RNA-based mechanisms[2][8]. Summary: RPL11P4 is not an actionable molecular target or receptor. It is a non-coding pseudogene without current utility as a drug target, biomarker, or therapeutic intervention point. If referencing the functional protein target, use Ribosomal protein L11 (RPL11) instead[1][7].

Other names

RPL11_2_1080RPL11P4